|
Play Video: The Importance of Insider Buying
|
|
|
The table below summarizes the most recent IMRA insider buying information, with links below the price to see the
CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many
possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more
information about why IMRA insider buys are important for investors to follow.
Date | Insider | Price | Amount |
10-24-2022 Insider Buy |
RA CAPITAL MANAGEMENT, L.P. >10% Owner |
$3.92
CAGR »
|
$336,811.50 85,902 shares |
10-19-2022 Insider Buy |
RA CAPITAL MANAGEMENT, L.P. >10% Owner |
$3.68
CAGR »
|
$1,860,961.40 506,197 shares |
5-17-2022 Insider Buy |
Braden Michael Leonard >10% Owner |
$1.23
CAGR »
|
$50,412.51 41,145 shares |
4-22-2022 Insider Buy |
Braden Michael Leonard >10% Owner |
$1.40
CAGR »
|
$783,840.00 560,000 shares |
2-23-2022 Insider Buy |
David M. Mott Director |
$1.45
CAGR »
|
$219,667.14 151,472 shares |
7-16-2021 Insider Buy |
David P. Bonita Director and >10% Owner |
$6.00
CAGR »
|
$9,999,996.00 1,666,666 shares |
3-16-2020 Insider Buy |
RA CAPITAL MANAGEMENT, L.P. >10% Owner |
$16.00
CAGR »
|
$10,000,000.00 625,000 shares |
3-16-2020 Insider Buy |
Barbara Dalton Director and >10% Owner |
$16.00
CAGR »
|
$5,000,000.00 312,500 shares |
3-16-2020 Insider Buy |
Mette Kirstine Agger Director and >10% Owner |
$16.00
CAGR »
|
$3,000,000.00 187,500 shares |
3-16-2020 Insider Buy |
New Enterprise Associates 14, L.P. >10% Owner |
$16.00
CAGR »
|
$7,600,000.00 475,000 shares |
3-16-2020 Insider Buy |
ORBIMED ADVISORS LLC Director and >10% Owner |
$16.00
CAGR »
|
$15,000,000.00 937,500 shares |
3-16-2020 Insider Buy |
Springs Capital Management LP Rock >10% Owner |
$16.00
CAGR »
|
$4,000,000.00 250,000 shares |
3-16-2020 Insider Buy |
Bioscience Plc Arix >10% Owner |
$16.00
CAGR »
|
$3,000,000.00 187,500 shares |
3-16-2020 Insider Buy |
Inc Pfizer >10% Owner |
$16.00
CAGR »
|
$5,000,000.00 312,500 shares |
3-16-2020 Insider Buy |
Invest A/S Lundbeckfond >10% Owner |
$16.00
CAGR »
|
$3,000,000.00 187,500 shares |
3-16-2020 Insider Buy |
Mark Chin Director and >10% Owner |
$16.00
CAGR »
|
$3,000,000.00 187,500 shares |
Also See: Institutional Holders of IMRA
Also See: SEC filings
Below we present the annualized performance delivered by IMRA stock since 10-24-2022 (the date of the most recent
insider purchase). The performance of the investment from the time IMRA insider buying occurred is the ultimate
test of whether insiders were right about IMRA being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
10/25/2022 |
|
End date: |
02/23/2023 |
|
Start price/share: |
$4.30 |
|
End price/share: |
$6.32 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
46.98% |
|
Annualized Gain: |
141.71% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$14,698.00 |
|
Years: |
0.33 |
|
IMRA Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent IMRA insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding IMRA
|
|